MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Read More →LTC Properties reports income jump in fourth quarter
LTC Properties saw steady returns and a higher net income than a year ago when it reported its finances for the fourth quarter of 2020. The Westlake Village-based real estate investment trust, which focuses on senior housing and health care properties, reported net income of $17.5 million, or 45 cents per diluted share, for 2020’s Read More →
Read More →
From the archives: J.D. Power’s entry into the Business Times Hall of Fame
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Westlake Village CEO faces charges over claims of 15-second COVID test
EDITOR’S NOTE: This article was updated Dec. 29 to include Keith Berman’s response to the allegations. Westlake Village-based Decision Diagnostics and its CEO, Keith Berman, face civil and criminal charges by federal agencies that accuse the company of falsely claiming it had developed technology that could almost instantly detect COVID-19 in a blood test. The Read More →
Read More →Westlake Village BioPartners puts $500 million into new venture funds
Westlake Village BioPartners, a venture capital firm focused on biotech startups in the Conejo Valley and the rest of greater Los Angeles, launched two new funds Dec. 15 worth a total of $500 million. The first fund is $70 million and will be used for Series B or later financing into companies that Westlake Village Read More →
Read More →MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
Read More →Guitar Center plans to file Chapter 11, cites pandemic’s effect on sales
Westlake Village-based Guitar Center plans to file for Chapter 11 bankruptcy, citing the pandemic as a major strain on the company’s resources. In a Nov. 13 news release, Guitar Center said that it had secured up to $165 million in new equity investments to recapitalize the company and reduce its corporate debt by nearly $800 Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
